1. Home
  2. SPRY vs DQ Comparison

SPRY vs DQ Comparison

Compare SPRY & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • DQ
  • Stock Information
  • Founded
  • SPRY 2015
  • DQ 2006
  • Country
  • SPRY United States
  • DQ China
  • Employees
  • SPRY 24
  • DQ N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • DQ Semiconductors
  • Sector
  • SPRY Health Care
  • DQ Technology
  • Exchange
  • SPRY Nasdaq
  • DQ Nasdaq
  • Market Cap
  • SPRY 1.4B
  • DQ 1.4B
  • IPO Year
  • SPRY N/A
  • DQ 2010
  • Fundamental
  • Price
  • SPRY $14.01
  • DQ $19.22
  • Analyst Decision
  • SPRY Strong Buy
  • DQ Hold
  • Analyst Count
  • SPRY 4
  • DQ 5
  • Target Price
  • SPRY $24.00
  • DQ $20.31
  • AVG Volume (30 Days)
  • SPRY 1.3M
  • DQ 2.5M
  • Earning Date
  • SPRY 11-13-2024
  • DQ 10-30-2024
  • Dividend Yield
  • SPRY N/A
  • DQ N/A
  • EPS Growth
  • SPRY N/A
  • DQ N/A
  • EPS
  • SPRY N/A
  • DQ N/A
  • Revenue
  • SPRY $2,568,000.00
  • DQ $1,310,019,000.00
  • Revenue This Year
  • SPRY $21,686.67
  • DQ N/A
  • Revenue Next Year
  • SPRY $956.61
  • DQ $47.79
  • P/E Ratio
  • SPRY N/A
  • DQ N/A
  • Revenue Growth
  • SPRY 8460.00
  • DQ N/A
  • 52 Week Low
  • SPRY $4.53
  • DQ $13.62
  • 52 Week High
  • SPRY $18.51
  • DQ $30.85
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 41.90
  • DQ 42.58
  • Support Level
  • SPRY $13.80
  • DQ $20.50
  • Resistance Level
  • SPRY $18.51
  • DQ $22.31
  • Average True Range (ATR)
  • SPRY 1.23
  • DQ 1.72
  • MACD
  • SPRY -0.24
  • DQ -0.54
  • Stochastic Oscillator
  • SPRY 12.62
  • DQ 0.29

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: